Cargando…

The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics

The understanding of etiology and pathogenesis of idiopathic immune myositis is fast evolving, and so is the classification of myositis subtypes. The diversity in genetics, major histocompatibility complex expressions, immunohistochemical, and specific and associated autoantibodies not only explains...

Descripción completa

Detalles Bibliográficos
Autor principal:	Patwardhan, Anjali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034746/ https://www.ncbi.nlm.nih.gov/pubmed/32128294 http://dx.doi.org/10.7759/cureus.7049

Ejemplares similares

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon
por: Patwardhan, Anjali, et al.
Publicado: (2019)

Atypical Power Doppler Ultrasound Findings in Juvenile Idiopathic Inflammatory Myositis (JIIM) Flare
por: Ewing, Brandon, et al.
Publicado: (2021)

Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis
por: Liu, Chang, et al.
Publicado: (2022)

Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Use of subcutaneous immunoglobulin in inflammatory myositis
por: Zhou, Alan L, et al.
Publicado: (2021)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
por: Yan, Fan, et al.
Publicado: (2020)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
por: Golhen, Klervi, et al.
Publicado: (2022)

The Utility and Experience with Disease Biomarkers in Juvenile Onset Arthritis vs. Adult Onset Arthritis
por: Patwardhan, Anjali
Publicado: (2019)

Sustained Positivity and Reinfection With SARS-CoV-2 in Children: Does Quarantine/Isolation Period Need Reconsideration in a Pediatric Population?
por: Patwardhan, Anjali
Publicado: (2020)

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021)

Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
por: Okulu, Emel, et al.
Publicado: (2022)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
por: Sedlin, E., et al.
Publicado: (2023)

Echovirus Type 7 Virus-Associated Hemophagocytic Syndrome in a Neonate Successfully Treated With Intravenous Immunoglobulin Therapy: A Case Report
por: Watanabe, Yuka, et al.
Publicado: (2019)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
por: Kuniyoshi, Yasutaka, et al.
Publicado: (2020)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

The Flu Vaccination May Have a Protective Effect on the Course of COVID-19 in the Pediatric Population: When Does Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Meet Influenza?
por: Patwardhan, Anjali, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome
por: Eremija, Jelena, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies
por: Liu, Gengying, et al.
Publicado: (2020)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
por: Choi, In Su, et al.
Publicado: (2022)

Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin
por: Suzuki, Takanori, et al.
Publicado: (2023)

Diagnostic value of MRI in inflammatory myositis
por: Lai, Tim Tien, et al.
Publicado: (2015)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
por: Jacob, Saiju, et al.
Publicado: (2009)

Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
por: Geerts, Margot, et al.
Publicado: (2021)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
por: Wu, Shu, et al.
Publicado: (2019)

Myositis, Osteomyelitis and a Parasymphyseal Stress Fracture in a Paediatric Patient
por: Hind, Jamie, et al.
Publicado: (2021)

Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial
por: Welzel, Tatjana, et al.
Publicado: (2022)

A Rare Case of Primary Mycobacterium tuberculosis Myositis of the Thigh in an Immunocompetent Infant
por: Helali, Hadi A, et al.
Publicado: (2023)

Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
por: Lim, Johan, et al.
Publicado: (2020)

Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis
por: Mecoli, Christopher A., et al.
Publicado: (2020)

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
por: Papadopoulou, Charalampia, et al.
Publicado: (2023)

12. When is inflammatory myositis not inflammatory myositis?
por: McShane, Annmarie, et al.
Publicado: (2019)

Prediction for Intravenous Immunoglobulin Resistance Combining Genetic Risk Loci Identified From Next Generation Sequencing and Laboratory Data in Kawasaki Disease
por: Chen, Liqin, et al.
Publicado: (2020)

A Machine Learning Model to Predict Intravenous Immunoglobulin-Resistant Kawasaki Disease Patients: A Retrospective Study Based on the Chongqing Population
por: Liu, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sg9bok8cgistrr5h90tq8l36ha